Literature DB >> 427773

Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer.

C O'Toole, B Unsgaard.   

Abstract

Peripheral blood lymphocytes and leukocyte levels were monitored in 34 patients with bladder carcinoma before, during, and up to 5 years after radiotherapy. Radiotherapy in doses 6500 to 8500 rads caused a marked decline in the numbers of circulating leukocytes and particularly lymphocytes. In patients clinically free of disease for 5 years, lymphocyte counts returned to pretherapy levels within 3 years after radiotherapy. In contrast, in patients with recurrent or residual tumors lymphocyte counts failed to reach pretherapy levels within 3 years after therapy. The rate of recovery from radiation-induced lymphopenia was significantly different for patients who were free of disease as compared to those with recurrent or residual tumor (p less than 0.05). No correlation was found between posttherapy leukocyte levels and clinical status.

Entities:  

Mesh:

Year:  1979        PMID: 427773

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.

Authors:  Joji Kitayama; Koji Yasuda; Kazushige Kawai; Eiji Sunami; Hirokazu Nagawa
Journal:  Radiat Oncol       Date:  2010-06-03       Impact factor: 3.481

2.  Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.

Authors:  Radhe Mohan; Amy Y Liu; Paul D Brown; Anita Mahajan; Jeffrey Dinh; Caroline Chung; Sarah McAvoy; Mary Frances McAleer; Steven H Lin; Jing Li; Amol J Ghia; Cong Zhu; Erik P Sulman; John F de Groot; Amy B Heimberger; Susan L McGovern; Clemens Grassberger; Helen Shih; Susannah Ellsworth; David R Grosshans
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

3.  Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.

Authors:  Joji Kitayama; Koji Yasuda; Kazushige Kawai; Eiji Sunami; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2011-02-10       Impact factor: 4.430

4.  Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis.

Authors:  Robert H Press; Joseph W Shelton; Chao Zhang; Quang Dang; Sibo Tian; Timothy Shu; Crystal S Seldon; Shaakir Hasan; Ashesh B Jani; Jun Zhou; Mark W McDonald
Journal:  Int J Part Ther       Date:  2021-07-06

5.  Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer.

Authors:  Chi Hwan Choi; Won Dong Kim; Sang Jeon Lee; Woo-Yoon Park
Journal:  Radiat Oncol J       Date:  2012-09-30

6.  Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome.

Authors:  Bhanu Prasad Venkatesulu; Amrish Sharma; Julianne M Pollard-Larkin; Ramaswamy Sadagopan; Jessica Symons; Shinya Neri; Pankaj K Singh; Ramesh Tailor; Steven H Lin; Sunil Krishnan
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.996

7.  Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.

Authors:  Mame Daro-Faye; Wassim Kassouf; Luis Souhami; Gautier Marcq; Fabio Cury; Tamim Niazi; Paul Sargos
Journal:  World J Urol       Date:  2020-09-11       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.